Literature DB >> 22430444

Clinical presentation of intoxication due to synthetic cannabinoids.

Joanna Cohen1, Sephora Morrison, Jeffrey Greenberg, Mohsen Saidinejad.   

Abstract

Synthetic cannabinoids are relatively novel substances of abuse. The use of these compounds among adolescents and young adults has been increasing, making it important for pediatric providers to be familiar with the presenting signs and symptoms of intoxication. We describe three case presentations of reported synthetic cannabinoid intoxication and provide a brief discussion of these compounds.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430444     DOI: 10.1542/peds.2011-1797

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

Review 1.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 2.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

3.  Bilateral multiple exudative retinal detachments and macular edema in a patient diagnosed with synthetic cannabinoid (Bonzai) intoxication.

Authors:  Ahmet Kırgız; Havva Kaldırım
Journal:  Int Ophthalmol       Date:  2017-12-23       Impact factor: 2.031

4.  Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.

Authors:  Francois R Lamy; Raminta Daniulaityte; Ramzi W Nahhas; Monica J Barratt; Alan G Smith; Amit Sheth; Silvia S Martins; Edward W Boyer; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2017-06-01

Review 5.  The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.

Authors:  Laura Orsolini; Stefania Chiappini; Duccio Papanti; Domenico De Berardis; John M Corkery; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2019-11-20       Impact factor: 4.157

Review 6.  Spicing things up: synthetic cannabinoids.

Authors:  Max Spaderna; Peter H Addy; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

7.  High times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use.

Authors:  Sameir Alhadi; Anupama Tiwari; Rais Vohra; Roy Gerona; Janak Acharya; Kathryn Bilello
Journal:  J Med Toxicol       Date:  2013-06

8.  Driving under the influence of synthetic cannabinoids ("Spice"): a case series.

Authors:  Frank Musshoff; Burkhard Madea; Gerhard Kernbach-Wighton; Wolfgang Bicker; Stefan Kneisel; Melanie Hutter; Volker Auwärter
Journal:  Int J Legal Med       Date:  2013-05-01       Impact factor: 2.686

Review 9.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

10.  Emergency physicians' knowledge of cannabinoid designer drugs.

Authors:  Patrick M Lank; Elizabeth Pines; Mark B Mycyk
Journal:  West J Emerg Med       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.